Cargando…

Effects of Norepinephrine Reuptake Inhibition on Postural Tachycardia Syndrome

BACKGROUND: Postural tachycardia syndrome (POTS) is a disorder of chronic orthostatic intolerance accompanied by excessive orthostatic tachycardia. Patients with POTS commonly have comorbid conditions such as attention deficit hyperactivity disorder, depression, or fibromyalgia that are treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Elizabeth A., Raj, Vidya, Shibao, Cyndya A., Biaggioni, Italo, Black, Bonnie K., Dupont, William D., Robertson, David, Raj, Satish R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835251/ https://www.ncbi.nlm.nih.gov/pubmed/24002370 http://dx.doi.org/10.1161/JAHA.113.000395

Ejemplares similares

Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes
por: Okamoto, Luis E., et al.
Publicado: (2011)

Splanchnic Venous Compression Enhances the Effects of ß‐Blockade in the Treatment of Postural Tachycardia Syndrome
por: Smith, Emily C., et al.
Publicado: (2020)

Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia: Role of Autonomic Modulation and Sinus Node Automaticity
por: Nwazue, Victor C., et al.
Publicado: (2014)

Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome – a case-control study
por: Rigo, Stefano, et al.
Publicado: (2023)

Symptom Presentation and Access to Medical Care in Patients With Postural Orthostatic Tachycardia Syndrome: Role of Sex
por: Bourne, Kate M., et al.
Publicado: (2021)

Long-Term Outcomes of Hyperadrenergic Orthostatic Hypotension
por: Castro, Robert Alexander, et al.
Publicado: (2023)

2198 Cognitive and behavioral side effects in patients treated with droxidopa for neurogenic orthostatic hypotension
por: McDonell, Katherine, et al.
Publicado: (2018)

The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based survey
por: Shaw, B. H., et al.
Publicado: (2019)

Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure
por: Arnold, Amy C., et al.
Publicado: (2014)

Fludrocortisone Is Associated With a Higher Risk of All‐Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension
por: Grijalva, Carlos G., et al.
Publicado: (2017)

The Gut Microbiota and Short-Chain Fatty Acids Profile in Postural Orthostatic Tachycardia Syndrome
por: Ishimwe, Jeanne A., et al.
Publicado: (2022)

The Postural Tachycardia Syndrome (POTS): Pathophysiology, Diagnosis & Management
por: Raj, Satish R
Publicado: (2006)

Neuronal and hormonal perturbations in postural tachycardia syndrome
por: Mar, Philip L., et al.
Publicado: (2014)

Diagnosis and management of postural orthostatic tachycardia syndrome
por: Raj, Satish R., et al.
Publicado: (2022)

Corrigendum: Neuronal and hormonal perturbations in postural tachycardia syndrome
por: Mar, Philip L., et al.
Publicado: (2019)

Differential Diagnosis of Vasovagal Syncope: Postural Orthostatic Tachycardia
por: Garland, Emily M., et al.
Publicado: (2014)

Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
por: Kaufmann, Horacio, et al.
Publicado: (2021)

Combined Norepinephrine/Serotonergic Reuptake Inhibition: Effects on Maternal Behavior, Aggression, and Oxytocin in the Rat
por: Cox, Elizabeth Thomas, et al.
Publicado: (2011)

Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2
por: Raj, Satish R., et al.
Publicado: (2021)

Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition
por: Connell, Charlotte J. W., et al.
Publicado: (2017)

Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension
por: Eisenhofer, Graeme, et al.
Publicado: (2021)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

A functional cell-based bioassay for assessing adrenergic autoantibody activity in postural tachycardia syndrome
por: Badiudeen, Thariq, et al.
Publicado: (2019)

Autoimmune Basis for Postural Tachycardia Syndrome
por: Li, Hongliang, et al.
Publicado: (2014)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
por: Fanelli, David, et al.
Publicado: (2021)

Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors
por: Paudel, Suresh, et al.
Publicado: (2021)

Development of norepinephrine transporter reuptake inhibition assays using SK-N-BE(2)C cells
por: Decker, Ann M., et al.
Publicado: (2018)

Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome
por: Zhang, Qingyou, et al.
Publicado: (2014)

Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan
por: Higuchi, Teruhiko, et al.
Publicado: (2007)

Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome
Publicado: (2016)

Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome
por: Benavides, David R., et al.
Publicado: (2016)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
por: Wen, Hui, et al.
Publicado: (2019)

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome
por: Yu, Xichun, et al.
Publicado: (2018)

Local Passive Heat for the Treatment of Hypertension in Autonomic Failure
por: Okamoto, Luis E., et al.
Publicado: (2021)

The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor
por: Kielbasa, William, et al.
Publicado: (2013)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)

Time‐Course Analysis of Flow Mediated Dilation for the Evaluation of Endothelial Function After a High‐Fat Meal in African Americans
por: Marinos, Alejandro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rgcpn6k76tclcslam6e3v0rr23